Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 3977Pancreatic Neoplasms 2478Carcinoma, Hepatocellular 2411Stomach Neoplasms 2108Rectal Neoplasms 1676Colonic Neoplasms 1629Esophageal Neoplasms 1311Liver Neoplasms 878Neoplasms 633Breast Neoplasms 596Cholangiocarcinoma 525Gastrointestinal Neoplasms 468Neoplasm Metastasis 456Esophageal Squamous Cell Carcinoma 434Lung Neoplasms 422Biliary Tract Neoplasms 277Prostatic Neoplasms 270Ovarian Neoplasms 235Barrett Esophagus 224Adenocarcinoma Of Esophagus 202Gallbladder Neoplasms 191Head and Neck Neoplasms 185Carcinoma, Non-Small-Cell Lung 185Gastrointestinal Stromal Tumors 180Anus Neoplasms 179Recurrence 168Melanoma 162Adenocarcinoma 156Uterine Cervical Neoplasms 153Bile Duct Neoplasms 153

Interventions

Gemcitabine 2epitumomab 1Long Interspersed Nucleotide Elements 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Anophthalmia with pulmonary hypoplasia × Gastrointestinal × Clear all
NCT05475366 2026-05-01

PACsign

Institut Curie

Phase NA Recruiting
85 enrolled
Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Carcinoma, Pancreatic Ductal

NCT06361030 2024-04-11

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Pancreatic Neoplasms

NCT02132403 2015-05-01

PM-01

University of Illinois at Chicago

Phase 1 Terminated
3 enrolled
Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡